Andrew Raubitschek

Institute of Neuroimmunology of the Slovak Academy of Sciences — SK

Medicine · Health Sciences

59h-index11.6kcitations219works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(98), Monoclonal and Polyclonal Antibodies Research(75), Lymphoma Diagnosis and Treatment(52), CAR-T cell therapy research(37), Medical Imaging Techniques and Applications(28)

Publications218 total

Data from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Table 1 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Data from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure 2 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure 1 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure 2 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure 1 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure 2 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure Legend from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Data from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure Legend from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure Legend from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure Legend from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure 1 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure 3 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Figure 3 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
Supplementary Table 1 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure 2 from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Data from Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
2023Open Access
Supplementary Figure 1 from Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2023Open Access
page 1 of 11Next →

Frequent Co-authors

John E. Shively(18), Anna M. Wu(17), Stephen J. Forman(15), Lawrence E. Williams(13), Paul J. Yazaki(10), David Colcher(10), Michael C. Jensen(9), Tove Olafsen(7), Jeffrey Y.C. Wong(6), Jinjuan Wang(5), Philip D. Greenberg(5), Oliver W. Press(5), Sanjiv S. Gambhir(5), Dave Yamauchi(5), Brian G. Till(4), Xiaojun Qian(4), Catherine Lindgren(4), Stanley R. Riddell(4), Gobalakrishnan Sundaresan(4), Vania Kenanova(4)